What's New on the FDA Drugs Site
July 10, 2014
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA posts draft guidances describing GDUFA performance metrics and associated webinars
- Guidance for Industry:
- National Drug Code Directory
- Potential Signals of Serious Risks/New Safety Information Identified from the FDA Adverse Event Reporting System (FAERS) (formerly AERS): 11 updated reports (updated)
New and Generic Drug Approvals
July 9, 2014
Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
---|---|---|---|---|
Aplenzin | bupropion hydrobromide | Tablet, Extended Release;Oral | Valeant Bermuda | Labeling Revision |
Cayston | aztreonam | For Solution;Inhalation | Gilead | Manufacturing Change or Addition |
Fortical | calcitonin salmon recombinant | Spray, Metered;Nasal | Upsher Smith | Labeling Revision |
Linzess | linaclotide | Capsule;Oral | Forest Labs Inc | Labeling Revision |